Crohn's disease trials recruiting in Pennsylvania

All Crohn's disease trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
  NCT06405087 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Hershey
• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
  NCT07184944 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
  NCT07499232 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Uniontown
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
  NCT05923073 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
  NCT07196722 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Harrisburg, Hershey, Philadelphia
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
  NCT05509777 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
  NCT06045754 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Pennsylvania: Wexford
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
  NCT05442567 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
  NCT04779320 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
  NCT06100289 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Hershey
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819891 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
  NCT06819878 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Hershey, Uniontown
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Hershey, Philadelphia, Uniontown
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
  NCT06637631 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Uniontown
• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
  NCT06958536 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Harrisburg
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
  NCT07184931 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• Autologous Stem Cell Transplantation for Crohn's Disease
  NCT00692939 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 60 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
  NCT07198113 · Phase: Not specified · Ages: 1 Year to 18 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
  NCT05781152 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
  NCT06332534 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
  NCT06918808 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
  NCT04528355 · Phase: Not specified · Ages: 2 Months to 60 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
  NCT06456593 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Harrisburg, Pittsburgh, Uniontown
• Inflammatory Bowel Disease (IBD) Research Registry
  NCT04243525 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
  NCT06864403 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
  NCT01962415 · Phase: Phase 2 · Ages: 2 Months to 55 Years · Sex: All (male and female) · Pennsylvania: Pittsburgh
• Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
  NCT06216899 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 21 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
  NCT06548542 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Hershey, Philadelphia
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh